Jim Sonner

Jim Sonner

Jim Sonner is the founder and CEO of BraneQuest, which is developing antiepileptic drugs to treat seizures that are not responsive to today’s medications, i.e. medically refractory seizures. His years of research on anesthetic mechanisms is informing his development of antiepileptic drugs since all anesthetics suppress seizures. Dr. Sonner received his MD from Harvard Medical School and has studied at a number of other institutions, including Harvey Mudd College in LA County, Harvard’s Graduate School of Arts and Sciences, Oxford University, Stanford University, and the University of California at San Francisco, where he is still a professor.